NASDAQ:ASLN

ASLAN Pharmaceuticals (ASLN) Stock Price, News & Analysis

ASLAN Pharmaceuticals logo
$0.60 0.00 (0.00%)
As of 11/6/2026

About ASLAN Pharmaceuticals Stock (NASDAQ:ASLN)

Advanced

Key Stats

Today's Range
$0.60
▼
$0.60
50-Day Range
$0.60
▼
$0.60
52-Week Range
$0.48
▼
$25.44
Volume
N/A
Average Volume
122,322 shs
Market Capitalization
$1.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ASLAN Pharmaceuticals is a Singapore-based biopharmaceutical company focused on developing treatments for immunological diseases. Its research has centered on therapies that target pathways involved in inflammatory conditions.

The company’s lead candidate, eblasakimab, is an antibody designed to block interleukin-13 receptor alpha 1 signaling and has been studied as a treatment for atopic dermatitis. ASLAN’s earlier pipeline also included ASLAN003, an investigational small-molecule drug studied for acute myeloid leukemia.

Founded in 2010, ASLAN has pursued drug development through clinical programs and collaborations spanning multiple markets. Its work has included research and development activities in Asia and the United States.

AI Generated. May Contain Errors.

Receive ASLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASLN Stock News Headlines

ELON + YOU + DECEMBER 8TH
Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.tc pixel
See More Headlines

ASLN Stock Analysis - Frequently Asked Questions

ASLAN Pharmaceuticals' stock was trading at $0.60 on January 1st, 2026. Since then, ASLN shares have increased by 0.0% and is now trading at $0.60.

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) issued its quarterly earnings results on Friday, August, 11th. The company reported ($0.88) earnings per share for the quarter, beating the consensus estimate of ($6.40) by $5.52. The company had revenue of $12 million for the quarter.

Shares of ASLAN Pharmaceuticals reverse split on Wednesday, July 3rd 2024.The 1-8 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

ASLAN Pharmaceuticals (ASLN) raised $60 million in an initial public offering on Friday, May 4th 2018. The company issued 7,500,000 shares at $8.05 per share. Leerink Partners and Piper Jaffray served as the underwriters for the IPO and BTIG, H.C. Wainwright and CLSA were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that ASLAN Pharmaceuticals investors own include NIO (NIO), Tesla (TSLA), FuelCell Energy (FCEL), Nabriva Therapeutics (NBRV), NVIDIA (NVDA), TherapeuticsMD (TXMD) and Actinium Pharmaceuticals (ATNM).

Company Calendar

Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ASLN
CIK
1722926
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($21.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.22 million
Net Margins
N/A
Pretax Margin
-290.83%
Return on Equity
-8,454.87%
Return on Assets
-121.60%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.05
Quick Ratio
1.05

Sales & Book Value

Annual Sales
$12 million
Price / Sales
0.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.50) per share
Price / Book
-0.09

Miscellaneous

Outstanding Shares
2,044,000
Free Float
1,948,000
Market Cap
$1.23 million
Optionable
No Data
Beta
1.40

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ASLN) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners